Literature DB >> 16382241

Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor.

Gregor B Adams1, Karissa T Chabner, Ian R Alley, Douglas P Olson, Zbigniew M Szczepiorkowski, Mark C Poznansky, Claudine H Kos, Martin R Pollak, Edward M Brown, David T Scadden.   

Abstract

During mammalian ontogeny, haematopoietic stem cells (HSCs) translocate from the fetal liver to the bone marrow, where haematopoiesis occurs throughout adulthood. Unique features of bone that contribute to a microenvironmental niche for stem cells might include the known high concentration of calcium ions at the HSC-enriched endosteal surface. Cells respond to extracellular ionic calcium concentrations through the seven-transmembrane-spanning calcium-sensing receptor (CaR), which we identified as being expressed on HSCs. Here we show that, through the CaR, the simple ionic mineral content of the niche may dictate the preferential localization of adult mammalian haematopoiesis in bone. Antenatal mice deficient in CaR had primitive haematopoietic cells in the circulation and spleen, whereas few were found in bone marrow. CaR-/- HSCs from fetal liver were normal in number, in proliferative and differentiative function, and in migration and homing to the bone marrow. Yet they were highly defective in localizing anatomically to the endosteal niche, behaviour that correlated with defective adhesion to the extracellular matrix protein, collagen I. CaR has a function in retaining HSCs in close physical proximity to the endosteal surface and the regulatory niche components associated with it.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16382241     DOI: 10.1038/nature04247

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  255 in total

1.  A multiscale model of the bone marrow and hematopoiesis.

Authors:  Ariosto Silva; Alexander R A Anderson; Robert Gatenby
Journal:  Math Biosci Eng       Date:  2011-04       Impact factor: 2.080

2.  The haematopoietic stem cell niche at a glance.

Authors:  Cristina Lo Celso; David T Scadden
Journal:  J Cell Sci       Date:  2011-11-01       Impact factor: 5.285

3.  Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.

Authors:  Steven W Lane; Serena De Vita; Kylie A Alexander; Ruchan Karaman; Michael D Milsom; Adrienne M Dorrance; Amy Purdon; Leeann Louis; Mary L Bouxsein; David A Williams
Journal:  Blood       Date:  2011-11-28       Impact factor: 22.113

Review 4.  Stem cell interactions in a bone marrow niche.

Authors:  Joan Isern; Simón Méndez-Ferrer
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

5.  Regulating traffic in the hematopoietic stem cell niche.

Authors:  Marc H G P Raaijmakers
Journal:  Haematologica       Date:  2010-09       Impact factor: 9.941

6.  Pharmacologic modulation of the calcium-sensing receptor enhances hematopoietic stem cell lodgment in the adult bone marrow.

Authors:  Ben S Lam; Cynthia Cunningham; Gregor B Adams
Journal:  Blood       Date:  2010-11-12       Impact factor: 22.113

Review 7.  Renal repair: role of bone marrow stem cells.

Authors:  Fangming Lin
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

8.  Calcium-Infiltrated Biphasic Hydroxyapatite Scaffolds for Human Hematopoietic Stem Cell Culture.

Authors:  Qinghao Zhang; Jörg C Gerlach; Ian Nettleship; Eva Schmelzer
Journal:  Tissue Eng Part A       Date:  2018-06-04       Impact factor: 3.845

9.  The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment.

Authors:  Mrinal K Das; Taral R Lunavat; Hrvoje Miletic; Jubayer A Hossain
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Osteoclasts are not crucial for hematopoietic stem cell maintenance in adult mice.

Authors:  Carmen Flores; Ilana Moscatelli; Christian S Thudium; Natasja Stæhr Gudmann; Jesper S Thomsen; Annemarie Brüel; Morten A Karsdal; Kim Henriksen; Johan Richter
Journal:  Haematologica       Date:  2013-10-04       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.